Gavi

Latest

U.S. Retreat from Gavi Cedes Influence to China's Vaccine Suppliers

The loss of U.S. funding could leave Gavi with three options to downsize its operations

A New Way to Drive COVID-19 Vaccine Development

How a "benefit-based advance market commitment" could build on existing Gavi COVAX and EU Joint Procurement initiatives